Profile data is unavailable for this security.
About the company
Guangxi LiuYao Group Co Ltd, formerly Guangxi Liuzhou Pharmaceutical Co Ltd, is a China-based company mainly engaged in the sales of pharmaceuticals. The Company is mainly engaged in three businesses. The pharmaceutical wholesale business mainly distributes pharmaceutical products to medical and health institutions at all levels, pharmaceutical distribution enterprises and chain pharmacies. The pharmaceutical retail business provides sales and health services of various pharmaceutical products, medical devices and other pharmaceutical products to individual consumers through terminal pharmacies. The pharmaceutical industry business is mainly engaged in the production and research and development of pharmaceuticals and medical devices. The Company is also engaged in supply chain value-added services, pharmaceutical Internet services, terminal health services, etc.
- Revenue in CNY (TTM)21.25bn
- Net income in CNY888.87m
- Incorporated1981
- Employees5.58k
- LocationGuangxi LiuYao Group Co LtdNo. 68, Guantang AvenueLIUZHOU 545000ChinaCHN
- Phone+86 7 722566078
- Fax+86 7 722566078
- Websitehttp://web.lzyy.cn/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NanJing Pharmaceutical Co Ltd | 53.46bn | 587.75m | 6.45bn | 4.90k | 11.04 | 0.9673 | -- | 0.1206 | 0.4457 | 0.4457 | 40.51 | 5.09 | 1.63 | 8.33 | 3.33 | 10,903,610.00 | 2.22 | 2.32 | 7.44 | 8.94 | 6.04 | 6.41 | 1.36 | 1.30 | 1.13 | 2.91 | 0.6359 | 29.82 | 6.71 | 11.35 | -3.00 | 16.93 | -12.67 | 9.86 |
| Guangxi LiuYao Group Co Ltd | 21.25bn | 888.87m | 9.25bn | 5.58k | 9.43 | 1.21 | -- | 0.4354 | 2.46 | 2.46 | 58.82 | 19.12 | 1.07 | 6.99 | 1.97 | 3,807,204.00 | 4.80 | 5.06 | 11.73 | 12.21 | 11.56 | 11.85 | 4.47 | 4.40 | 1.30 | 5.26 | 0.5434 | 29.90 | 9.23 | 12.18 | 21.11 | 9.97 | -8.63 | 6.26 |
| GuangYuYuan Chinese Herbal Medicn Co Ltd | 1.26bn | 121.59m | 12.27bn | 1.81k | 100.88 | 7.98 | -- | 9.75 | 0.2484 | 0.2484 | 2.57 | 3.14 | 0.4701 | 0.7661 | 1.99 | 694,836.90 | 4.96 | -2.10 | 7.42 | -3.16 | 71.43 | 69.74 | 10.56 | -6.00 | 1.16 | 12.91 | 0.1569 | -- | 13.56 | -4.53 | 136.03 | -24.78 | -58.35 | -- |
| Tibet Rhodiola Pharmaceutical Holding Co | 2.93bn | 810.63m | 12.59bn | 601.00 | 13.92 | 2.65 | -- | 4.29 | 2.81 | 2.81 | 9.65 | 14.76 | 0.6016 | 1.81 | 6.68 | 4,877,892.00 | 16.83 | 12.44 | 23.18 | 15.71 | 93.68 | 90.51 | 27.97 | 20.43 | 2.79 | 7.96 | 0.1716 | 50.41 | 22.69 | 24.98 | 116.56 | 30.01 | -1.48 | 48.97 |
| Holder | Shares | % Held |
|---|---|---|
| Zhong Geng Fund Management Co. , Ltd.as of 30 Jun 2023 | 34.32m | 9.48% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2023 | 10.56m | 2.92% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2023 | 7.56m | 2.09% |
| HuaAn Fund Management Co., Ltd.as of 30 Jun 2023 | 6.72m | 1.86% |
| CITIC Securities Co., Ltd. (Invt Port)as of 30 Sep 2023 | 6.16m | 1.70% |
| GF Fund Management Co., Ltd.as of 30 Jun 2023 | 5.98m | 1.65% |
| Essence Fund Co., Ltd.as of 30 Jun 2023 | 2.38m | 0.66% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2023 | 2.30m | 0.63% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2023 | 2.18m | 0.60% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 1.91m | 0.53% |
